Search

China pioneers biosecurity report against ASF

Boehringer Ingelheim compiles data from 1,000 swine farms into the first market report on biosecurity. Document sheds light on livestock management and contributes to the fight against African swine fever.

Boehringer unveils first global sustainability publication

Boehringer Ingelheim unveils its first global sustainability publication ‘Imagine’

Boehringer Ingelheim acquires Nerio Therapeutics

Today marks a significant step for Boehringer Ingelheim’s immuno-oncology pipeline by adding an innovative preclinical program with the acquisition of Nerio Therapeutics

Collaboration Boehringer Ingelheim Veeva technology

Boehringer Ingelheim selects Veeva Development Cloud worldwide to bring innovative therapies to patients faster

Boehringer Ingelheim Second Transforming Science Day

World-renowned top scientists and companies in R&D take the stage at Boehringer Ingelheim’s second Transforming Science Day

How dangerous is the mpox virus?

Mpox, formerly known as monkeypox: What exactly is this virus, how is it transmitted, and what are the most noticeable symptoms?

Patient Safety & Pharmacovigilance at Boehringer Ingelheim

Patients inspire us in our mission to lead the science that creates breakthrough therapies, so that our medicines transform patients’ lives.

Launch of Frontline flagship store on Tmall

Boehringer Ingelheim launches Frontline flagship store on Tmall to sell selling full range of pet parasiticides.

New exchange platform with Harbin Research Institute

Boehringer Ingelheim and Harbin Veterinary Research Institute set up ‘industry-academia-research’ exchange platform

About Boehringer Ingelheim Partnering Days

Find out more about our partnering days and how we can work together to accelerate your science

1885-1948: Innovative beginnings

The Boehringer Ingelheim history from its start in 1885 to 1948, with milestones and important products

Breakthrough Designation granted in US and China

SPEVIGO® granted Breakthrough Therapy Designation in the U.S. for the prevention of generalized pustular psoriasis flares

Boehringer Ingelheim leader in hatchery vaccination

Boehringer Ingelheim is a leader in hatchery vaccination with vector vaccines.

Boehringer Ingelheim partners with GNA Biosolutions

Boehringer Ingelheim partners with GNA Biosolutions to develop African swine fever diagnostic test.

Boehringer Ingelheim Advances Oncology Research

Boehringer Ingelheim Advances Its Oncology Research Program Through Innovative Partnerships

Partnership for first-in-class cancer and CRM treatments

Boehringer Ingelheim partners with OSE Immunotherapeutics to develop first-in-class cancer and CRM treatments

Welcome to Innovation at Boehringer Ingelheim

Watch our video and find out more about innovation at Boehringer Ingelheim.

What do you know about transboundary animal diseases

Transboundary animal diseases (TADs) are highly transmissible diseases of livestock that can impact veterinary public health preparedness.

Monoclonal antibodies Boehringer Ingelheim and Invetx

Boehringer Ingelheim and Invetx announce collaboration to discover, develop and commercialize novel veterinary monoclonal antibody biotherapeutics

10 things you should know about rabies

Life forward - Boehringer Ingelheim company brand

Life forward - Boehringer Ingelheim unveils its evolved company brand

Boehringer Ingelheim 2022 half year results

First half of 2022: Boehringer Ingelheim continues growth pace and strengthens research pipeline

Two new claims for Nexgard range in EU and Australia

Boehringer Ingelheim expands the label claims of its NexGard® brands for the treatment of two severe skin diseases in dogs in the EU and in Australia.

FDA approval NexGard PLUS for dogs

Boehringer Ingelheim Receives FDA Approval for NexGard® PLUS - A Beef-Flavored Soft Chew That Protects Dogs from Internal and External Parasites

2020-Positive-business-momentum-despite-COVID-19-impact

While stepping up its investments in R&D significantly, Boehringer Ingelheim achieved a solid business performance in 2020 despite the COVID-19 pandemic.

About Us

Human Health

Animal Health

Science & Innovation

Partnering

Careers